671 related articles for article (PubMed ID: 10425102)
21. 2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong BS; Jeong TC; Lee CS; Lee ES
Bioorg Med Chem; 2007 Jul; 15(13):4351-9. PubMed ID: 17493824
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and cytotoxic activity of a new series of topoisomerase I inhibitors.
Dallavalle S; Gattinoni S; Mazzini S; Scaglioni L; Merlini L; Tinelli S; Beretta GL; Zunino F
Bioorg Med Chem Lett; 2008 Feb; 18(4):1484-9. PubMed ID: 18248813
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antitumor activity of 4-aminomethylthioxanthenone and 5-aminomethylbenzothiopyranoindazole derivatives.
Perni RB; Wentland MP; Huang JI; Powles RG; Aldous S; Klingbeil KM; Peverly AD; Robinson RG; Corbett TH; Jones JL; Mattes KC; Rake JB; Coughlin SA
J Med Chem; 1998 Sep; 41(19):3645-54. PubMed ID: 9733489
[TBL] [Abstract][Full Text] [Related]
24. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
[TBL] [Abstract][Full Text] [Related]
25. The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells.
Bonjean K; De Pauw-Gillet MC; Defresne MP; Colson P; Houssier C; Dassonneville L; Bailly C; Greimers R; Wright C; Quetin-Leclercq J; Tits M; Angenot L
Biochemistry; 1998 Apr; 37(15):5136-46. PubMed ID: 9548744
[TBL] [Abstract][Full Text] [Related]
26. The 1'-substituent on the anilino ring of the antitumor drug amsacrine is a critical element for topoisomerase II inhibition and cytotoxicity.
Rene B; Fosse P; Khelifa T; Jacquemin-Sablon A; Bailly C
Mol Pharmacol; 1996 Feb; 49(2):343-50. PubMed ID: 8632768
[TBL] [Abstract][Full Text] [Related]
27. [NB 506].
Lansiaux A; Bailly C
Bull Cancer; 1999 Mar; 86(3):255-8. PubMed ID: 10210758
[No Abstract] [Full Text] [Related]
28. Relationships between topoisomerase II inhibition, sequence-specificity and DNA binding mode of dicationic diphenylfuran derivatives.
Bailly C; Dassonneville L; Carrasco C; Lucas D; Kumar A; Boykin DW; Wilson WD
Anticancer Drug Des; 1999 Feb; 14(1):47-60. PubMed ID: 10363027
[TBL] [Abstract][Full Text] [Related]
29. Chromophore-modified bisnaphthalimides: DNA recognition, topoisomerase inhibition, and cytotoxic properties of two mono- and bisfuronaphthalimides.
Bailly C; Carrasco C; Joubert A; Bal C; Wattez N; Hildebrand MP; Lansiaux A; Colson P; Houssier C; Cacho M; Ramos A; Braña MF
Biochemistry; 2003 Apr; 42(14):4136-50. PubMed ID: 12680768
[TBL] [Abstract][Full Text] [Related]
30. Eukaryotic DNA topoisomerases mediated DNA cleavage induced by a new inhibitor: NSC 665517.
Gupta M; Abdel-Megeed M; Hoki Y; Kohlhagen G; Paull K; Pommier Y
Mol Pharmacol; 1995 Oct; 48(4):658-65. PubMed ID: 7476891
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.
Morrell A; Antony S; Kohlhagen G; Pommier Y; Cushman M
Bioorg Med Chem Lett; 2004 Jul; 14(14):3659-63. PubMed ID: 15203138
[TBL] [Abstract][Full Text] [Related]
32. Calories from carbohydrates: energetic contribution of the carbohydrate moiety of rebeccamycin to DNA binding and the effect of its orientation on topoisomerase I inhibition.
Bailly C; Qu X; Graves DE; Prudhomme M; Chaires JB
Chem Biol; 1999 May; 6(5):277-86. PubMed ID: 10322124
[TBL] [Abstract][Full Text] [Related]
33. Poisoning of topoisomerase I by an antitumor indolocarbazole drug: stabilization of topoisomerase I-DNA covalent complexes and specific inhibition of the protein kinase activity.
Labourier E; Riou JF; Prudhomme M; Carrasco C; Bailly C; Tazi J
Cancer Res; 1999 Jan; 59(1):52-5. PubMed ID: 9892183
[TBL] [Abstract][Full Text] [Related]
34. Novel synthetic isoquinolino[5,4-ab]phenazines: inhibition toward topoisomerase I, antitumor and DNA photo-cleaving activities.
Yang P; Yang Q; Qian X; Cui J
Bioorg Med Chem; 2005 Nov; 13(21):5909-14. PubMed ID: 16115776
[TBL] [Abstract][Full Text] [Related]
35. Enhanced binding to DNA and topoisomerase I inhibition by an analog of the antitumor antibiotic rebeccamycin containing an amino sugar residue.
Bailly C; Qu X; Anizon F; Prudhomme M; Riou JF; Chaires JB
Mol Pharmacol; 1999 Feb; 55(2):377-85. PubMed ID: 9927631
[TBL] [Abstract][Full Text] [Related]
36. Novel antitumor indenoindole derivatives targeting DNA and topoisomerase II.
Bal C; Baldeyrou B; Moz F; Lansiaux A; Colson P; Kraus-Berthier L; Léonce S; Pierré A; Boussard MF; Rousseau A; Wierzbicki M; Bailly C
Biochem Pharmacol; 2004 Nov; 68(10):1911-22. PubMed ID: 15476662
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of the action of the topoisomerase II poison amsacrine by simple aniline derivatives: evidence for drug-protein interactions.
Finlay GJ; Atwell GJ; Baguley BC
Oncol Res; 1999; 11(6):249-54. PubMed ID: 10691026
[TBL] [Abstract][Full Text] [Related]
38. Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effects.
De Isabella P; Capranico G; Palumbo M; Sissi C; Krapcho AP; Zunino F
Mol Pharmacol; 1993 May; 43(5):715-21. PubMed ID: 8388987
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines.
Karki R; Thapa P; Kang MJ; Jeong TC; Nam JM; Kim HL; Na Y; Cho WJ; Kwon Y; Lee ES
Bioorg Med Chem; 2010 May; 18(9):3066-77. PubMed ID: 20392646
[TBL] [Abstract][Full Text] [Related]
40. Benzo[f]azino[2,1-a]phthalazinium cations: novel DNA intercalating chromophores with antiproliferative activity.
Martínez V; Burgos C; Alvarez-Builla J; Fernández G; Domingo A; García-Nieto R; Gago F; Manzanares I; Cuevas C; Vaquero JJ
J Med Chem; 2004 Feb; 47(5):1136-48. PubMed ID: 14971893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
